Skip to content

Investors
Press Releases
About Us
Contact

Science
Sepranolone
Tourette Syndrome
OCD
PMDD

Science
Sepranolone
Tourette Syndrome
OCD
PMDD

Investors
Press Releases
About Us
Contact

PRIVATA AFFÄRER

2018-07-292019-12-01

Asarina Pharma en bra lottsedel för bioteknikfans (Asarina Pharma a safe bet for biotech fans)

Swedish investor paper’s positive report on Asarina Pharma.

Asarina Pharma AB
Registered office in Solna, Sweden
Reg no 556698-0750
© All rights reserved

Neve | Powered by WordPress

Contact

Asarina Pharma AB
Karolinska Institutet Science Park
Fogdevreten 2
SE – 171 65 Solna, Sweden

Navigation

Home
Science
Sepranolone
Menstrual Migraine
Tourette Syndrome
PMDD
Investors
Press Releases
About Us
Contact

About Asarina Pharma

Asarina Pharma is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion, menstrual and neurological disorders. Our product pipeline is built on over 40 years of research into llopregnanolone-related neurological disorders. With our new family of GAMSA compounds (GABA-A Modulating Steroid Antagonists) we aim to deliver a new generation of efficacious and safe drugs for still widely untreated neuroendocrinological conditions.

Asarina Pharma AB
Registered office in Solna, Sweden
Reg no 556698-0750
© All rights reserved

Neve | Powered by WordPress

Contact

Asarina Pharma AB
Karolinska Institutet Science Park
Fogdevreten 2
SE – 171 65 Solna, Sweden

Navigation

Home
Science
Sepranolone
Menstrual Migraine
Tourette Syndrome
PMDD
Investors
Press Releases
About Us
Contact

About Asarina Pharma

Asarina Pharma is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion, menstrual and neurological disorders. Our product pipeline is built on over 40 years of research into llopregnanolone-related neurological disorders. With our new family of GAMSA compounds (GABA-A Modulating Steroid Antagonists) we aim to deliver a new generation of efficacious and safe drugs for still widely untreated neuroendocrinological conditions.